Microdevices for screening biomolecules

• US 20020110932A1
• Filed: 03/29/2002
• Published: 08/15/2002
• Est. Priority Date: 07/14/1998
• Status: Abandoned Application

• Current Assignee: Zyomyx, Inc.
• Original Assignee: Zyomyx, Inc.
• Inventors: Wagner, Peter, Itin, Christian, Nock, Steffen, Ault-Riche, Dana
• Application Number:
  US10/112,982
• Publication Number:
  US 20020110932A1
• Time in Patent Office: Days
• US Class Current: 436/518
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: Y10S 435/805 Test papers
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]

Abstract

Methods and devices for the parallel, in vitro screening of biomolecular activity using miniaturized microfabricated devices are provided. The biomolecules immobilized on the surface of the devices of the present invention include proteins, polypeptides, polynucleotides, polysaccharides, phospolipids, and related unnatural polymers of biological relevance. These devices are useful drug development, functional proteomics and clinical diagnostics and are preferably used for the parallel screening of families of related proteins.

Claims

1. A device for analyzing components of a fluid sample, having a plurality of noncontiguous reactive sites, each of said sites comprising:

(a) a substrate;

(b) an organic thinfilm chemisorbed or physisorbed on a portion of the surface of said substrate; and

(c) a biological moiety immobilized on said organic thinfilm;

wherein each of said sites may independently react with a component of the fluid sample and are separated from each other by a region of said substrate that is free of said organic thinfilm.

2. The device of claim 1, further comprising an affinity tag, wherein said biological moiety is immobilized to said organic thinfilm by said affinity tag.

3. The device of claim 1, wherein the organic thinfilm is less than about 20 nm thick.

4. The device of claim 1, wherein said organic thinfilm comprises a monolayer.

5. The device of claim 1, wherein the monolayer comprises a self-assembled monolayer comprising molecules of the formula

(X)_aR(Y)_b

wherein R is a spacer, X is a functional group that binds R to the surface, Y is a functional group for binding the biological moiety onto the monolayer, and a and b are, independently, integers.

6. The device of claim 5, wherein both a and b are 1.

7. The device of claim 5, wherein:

said substrate is selected from the group consisting of silicon, silicon dioxide, indium tin oxide, alumina, glass, and titania; and

X, prior to incorporation into said monolayer, is selected from the group consisting of a monohalosilane;

dihalosilane, trihalosilane, trichlorosilane, trialkoxysilane, dialkoxysilane, monoalkoxysilane, carboxylic acid, and phosphate.

8. The device of claim 5, wherein the substrate comprises silicon and X is an olefin.

9. The device of claim 1, wherein the substrate comprises a polymer.

10. The device of claim 5, further comprising at least one coating between said substrate and said monolayer, wherein said coating is formed on the substrate or applied to the substrate.

11. The device of claim 10, wherein:

said coating comprises a noble metal film; and

X, prior to incorporation into said monolayer, is a functional group selected from the group consisting of an asymmetrical or symmetrical disulfide, sulfide, diselenide, selenide, thiol, isonitrile, selenol, trivalent phosphorus compounds, isothiocyanate, isocyanate, xanthanate, thiocarbamate, phosphines, amines, thio acid and dithio acid.

12. The device of claim 10, wherein the coating comprises titania or tantalum oxide and X is a phosphate group.

13. The device of claim 2, further comprising an adaptor that links the affinity tag to the immobilized biological moiety.

14. The device of claim 1 which comprises at least about 10 reactive sites.

15. The device of claim 13 which comprises at least about 100 reactive sites.

16. The device of claim 1 which comprises at least about 10 different immobilized biological moieties.

17. The device of claim 16 which comprises at least about 100 different immobilized biological moieties.

18. The device of claim 1, wherein all of the biological moieties on the reactive sites are functionally related.

19. The device of claim 1, wherein all of the biological moieties on the reactive sites are structurally related.

20. The device of claim 1, wherein the biological moiety is a polynucleotide.

21. The device of claim 1, wherein the biological moiety is a protein.

22. The device of claim 21, wherein all of the biological moieties on the reactive sites are members of the same protein family.

23. The device of claim 22, wherein the protein family is selected from the group consisting of growth factor receptors, hormone receptors, neurotransmitter receptors, catecholamine receptors, amino acid derivative receptors, cytokine receptors, extracellular matrix receptors, antibodies, lectins, cytokines, serpins, proteases, kinases, phosphatases, ras-like GTPases, hydrolases, steroid hormone receptors, transcription factors, heat-shock transcription factors, DNA-binding proteins, zinc-finger proteins, leucine-zipper proteins, homeodomain proteins, intracellular signal transduction modulators and effectors, apoptosis-related factors, DNA synthesis factors, DNA repair factors, DNA recombination factors, cell-surface antigens, hepatitis C virus (HCV) proteases and HIV proteases.

24. The device of claim 21, wherein the biological moiety is an antibody or an antibody fragment.

25. The device of claim 1, wherein the biological moiety is a protein-capture agent.

26. The device of claim 1, wherein said device comprises a micromachined or microfabricated device.

27. The device of claim 1, wherein each of said reactive sites is in a microchannel oriented parallel to microchannels of other reactive sites on the device, wherein said microchannels are microfabricated into or onto said substrate.

28. The device of claim 27, wherein said device comprises at least about 10 microchannels.

29. The device of claim 28, wherein said device comprises from about 100 to about 500 microchannels.

30. The device of claim 27, wherein said device comprises from about 2 to about 500 parallel microchannels per cm².

31. The device of claim 27, further comprising a cover over the microchannels.

32. The device of claim 31, wherein the volume of said microchannel is between about 5 nanoliters and about 300 nanoliters.

33. The device of claim 32, wherein the volume of said microchannel is between about 10 nanoliters and about 50 nanoliters.

34. The device of claim 27, wherein the width and depth of said microchannel each are between about 10 μ

m and about 500 μ

m.

35. A method for screening a plurality of different biological moieties in parallel for their ability to interact with a component of a fluid sample, comprising:

(a) delivering the fluid sample to the reactive sites of a device of claim 1, wherein each of the different biological moieties is immobilized on a different reactive site of the device; and

(b) detecting, either directly or indirectly, the interaction of said component with the immobilized biological moiety at each reactive site.

36. A method for screening a plurality of different biological moieties in parallel for their ability to react with a component of a fluid sample, comprising:

(a) delivering the fluid sample to the reactive sites of a device of claim 1, wherein each of the different biological moieties is immobilized on a different reactive site of the device; and

(b) detecting, either directly or indirectly, formation of product of the reaction of said component with the immobilized biological moiety at each reactive site.

37. A method for screening a plurality of biological moieties in parallel for their ability to bind a component of a fluid sample, comprising:

(a) delivering said fluid sample to the reactive sites of a device of claim 1, wherein each different biological moiety is immobilized on a different reactive site of the device; and

(b) detecting, either directly or indirectly, the presence or amount of said component retained at each reactive site.

38. A method for screening a plurality of components in separate fluid samples for their ability to interact with a biological moiety, comprising:

(a) delivering each of the different fluid samples to separate reactive sites of the device of claim 1, wherein the separate reactive sites of the device each comprise the immobilized biological moiety; and

(b) detecting, either directly or indirectly, for the interaction of the immobilized biological moiety at each reactive site with the component delivered to that reactive site.

39. A method for screening a plurality of binding candidates in parallel for their ability to bind a biological moiety, comprising:

(a) delivering different fluid samples, each containing at least one of the binding candidates, to separate reactive sites of the device of claim 1, wherein the separate reactive sites each comprise the immobilized biological moiety; and

(b) detecting, either directly or indirectly, for the presence or amount of said binding candidate retained at each reactive site.

40. A method for screening a plurality of different proteins in parallel for their ability to interact with a particular protein, comprising:

(a) delivering different fluid samples, each containing at least one of the different proteins, to separate reactive sites of the device of claim 1, wherein the particular protein is immobilized on each of the separate reactive sites; and

(b) detecting, either directly or indirectly, for the interaction of the particular protein with the different proteins at each of the reactive sites.

41. A method for pairing a plurality of proteins with their substrates, comprising:

(a) delivering a fluid sample comprising a substrate of a known enzyme family to the reactive sites of a device of claim 1, wherein each reactive site of the device comprises a different immobilized protein; and

(b) detecting, either directly or indirectly, for product formed by the reaction of the substrate with the immobilized protein of each reactive site.

42. A method for pairing a plurality of proteins with their ligands, comprising:

(a) delivering a fluid sample comprising a ligand of a known protein family to the reactive sites of a device of claim 1, wherein each reactive site of the device comprises a different protein; and

(b) detecting, either directly or indirectly, for the presence or amount of the ligand retained at each reactive site.

43. A method for detecting in a fluid sample the presence of a plurality of analytes, comprising:

(a) delivering the fluid sample to the reactive sites of a device of claim 1, wherein a biological moiety which reacts with one of said analytes is immobilized on each of the reactive sites; and

(b) detecting for the interaction of the analyte with the immobilized biological moiety at each reactive site.

44. A method for detecting in a fluid sample the presence of a plurality of analytes, comprising:

(a) delivering the fluid sample to the reactive sites of a device of claim 1, wherein a biological moiety which binds one of said analytes is immobilized on each of the reactive sites; and

(b) detecting, either directly or indirectly, for the presence of analyte retained at each reactive site.

45. A device for analyzing components of a fluid sample, comprising:

(a) a substrate;

(b) a plurality of parallel microchannels microfabricated into or onto said substrate; and

(c) a biological moiety immobilized within at least one of said parallel microchannels, wherein said biological moiety may interact with a component of the fluid sample.